User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Advanced Oncotherapy Plc

Advanced Oncotherapy (AVO)

Company name:Advanced Oncotherapy Plc
EPIC:AVOTrading Currency:GBX
Market Sector:AIMPISIN:GB00BD6SX109
Market Segment:ASX1Share Type:DE
WWW Address: 25P
 Price Price Change [%] Bid Offer Open High Low Volume
 36.00 0.0 [0.00] 35.00 37.00 36.00 36.00 36.00 6,003
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 125.78 349.40 -0.02 -9.83 - - - 48.50 - 24.50

Advanced Oncotherapy Key Figures

(at previous day's close)
Market Cap.125.78m
Shares In Issue349.40m
Prev. Close36.00
PE Ratio- 
Dividend Yield-%
EPS - basic-9.83p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-6.74p
Return On Equity (ROE)-48.43%
Operating Margin-%
PEG Factor- 
EPS Growth Rate30.04%
Dividends PS Growth Rate-%
Net Debt64.65m
Gross Gearing61.26%
Quick Assets8.06m
Net Working Capital16.63m
Intangibles / Fixed Assets93.16%
Turnover PS-p
Pre-Tax Profit PS-6.26p
Retained Profit PS-5.95p
Cash PS0.93p
Net Cash PS-0.93p
Net Tangible Asset Value PS *-11.10p
Net Asset Value PS12.29p
Spread2.00 (5.41%) 

Advanced Oncotherapy Balance Sheet


Share Price Performance

Sample Period HighLow
1 week37.0036.00
4 weeks39.0034.50
12 weeks43.5034.50
1 year48.5024.50

Share Price Chart (5 years)

Advanced Oncotherapy Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week37.00-1.00-2.7036.000.1436.02
4 weeks39.00-3.00-7.6934.500.1537.37
12 weeks43.50-7.50-17.2434.500.1439.31
26 weeks30.505.5018.0328.000.1838.78
1 year28.008.0028.5724.500.1634.91
3 years53.00-17.00-32.0820.500.1238.02
5 years156.25-120.25-76.969.750.2171.51

Advanced Oncotherapy Key Management Ratios

Advanced Oncotherapy Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.48 
Tobin's Q Ratio (excl. intangibles)5.20 
Dividend Yield-%
Market-to-Book Ratio2.93 
Price-to-Pre-Tax Profit PS-5.75 
Price-to-Retained Profit PS-6.05 
Price-to-Cash Flow PS-5.34 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS-3.24 
Price-to-Cash PS38.88 
Net Working Capital PS4.76 
Price Pct to Working Capital PS7.56%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Advanced Oncotherapy Financial Ratios

(Leverage Ratios)
Debt Ratio58.85%
Debt-to-Equity Ratio1.43 
Debt-to-Equity Ratio (excl. Intgbl)-1.58 
Debt-to-Equity Market Value0.49 
Net Gearing58.34%
Net Gearing (excl. Intangibles)222.09%
Gross Gearing61.26%
Gross Gearing (excl. Intangibles)233.21%
Gearing Under 1 Year5.84%
Gearing Under 1 Year (excl. Intgbl)22.25%
(Liquidity Ratios)
Net Working Capital to Total Assets15.01%
Current Ratio3.57 
Quick Ratio (Acid Test)1.24 
Liquidity Ratio0.50 
Cash & Equiv/Current Assets14.00%
(Solvency Ratios)
Enterprise Value183.96m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.54 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-3.10 
Total Debt67.89m
Total Debt/Net Current Assets4.08%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-17.57%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

Advanced Oncotherapy Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-20.97%
Return On Assets (ROA)-24.43%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-48.43%
Return On Investment (ROI)-26.86%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Advanced Oncotherapy Dividends

Sorry No Data Available

Advanced Oncotherapy Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-13.18--16.49--21.87--21.88-m
attributable profit-10.35--13.66--21.15--20.79-m
retained profit-10.35--13.66--21.15--20.79-m
eps - basic (p)-17.01 -17.55 -14.05 -9.83 
eps - diluted (p)-17.01 -17.55 -14.05 -9.83 
dividends per share- - - - 

Advanced Oncotherapy Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets1.463.89%1.182.60%4.096.87%6.005.42%m
intangibles intangibles23.3662.00%30.5767.33%40.1767.56%81.7173.73%m
fixed investments fixed investments0.310.82%0.310.68%0.310.52%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks7.4419.74%7.6316.80%10.0116.84%15.0513.58%m
debtors debtors3.659.70%5.6512.45%3.866.50%4.824.35%m
cash & securities cash & securities1.453.85%0.060.12%1.011.70%3.242.92%m
creditors - short creditors - short3.689.76%16.7436.87%8.9515.06%6.485.84%m
creditors - long creditors - long--%--%16.5027.75%61.4155.41%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves33.9990.24%28.6663.13%34.0057.18%42.9438.74%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Advanced Oncotherapy Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-10.93-9.59-1.64-23.53m
Pre-Financing CF-20.59-18.15-13.72-35.23m
Retained CF-7.51-1.390.912.23m

Advanced Oncotherapy Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Advanced O..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210508 17:30:13